查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953554

二氧化碳監測設備市場 - 全球產業規模、佔有率、趨勢、機會及預測（按組件、應用、技術、類型、最終用戶、地區和競爭格局分類），2021-2031年

Capnography Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Component, By Application, By Technology, By Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球二氧化碳監測設備市場預計將從 2025 年的 6.8462 億美元成長到 2031 年的 12.2747 億美元，複合年成長率為 10.22%。

這些非侵入性診斷設備在臨床環境中至關重要，它們用於測量呼出二氧化碳水平，以評估患者的通氣狀態和循環系統健康狀況。市場成長趨勢的主要促進因素是全球慢性呼吸系統疾病發生率的上升，以及醫療安全標準的嚴格實施，這些標準要求在鎮靜和麻醉期間持續監測二氧化碳水平。根據美國重症醫學會 (SCCM) 的數據，到 2024 年，全球約有 5,000 萬人患有敗血症，這凸顯了加護病房迫切需要可靠的生理監測設備來有效控制這種危險疾病。

市場概覽
預測期 2027-2031
市場規模：2025年 6.8462億美元
市場規模：2031年 1,227,470,000 美元
複合年成長率：2026-2031年 10.22%
成長最快的細分市場 側流
最大的市場 北美洲

然而，限制市場擴張的一大障礙是先進二氧化碳測量儀系統所需的大量資本投入，這給經濟低度開發地區的醫療機構造成了進入門檻。此外，熟練二氧化碳測量儀數據解讀方法的醫護人員短缺，更使這一經濟障礙雪上加霜，阻礙了預算緊張的醫療網路廣泛採用這些關鍵技術。

市場促進因素

嚴格的監管要求，尤其是針對手術鎮靜和麻醉安全性的監管要求，是推動市場發展的主要動力。在全球範圍內，專業協會和監管機構已實施嚴格的通訊協定，強制要求在手術過程中持續監測吐氣末二氧化碳（ETCO2），以避免呼吸系統併發症。這些措施對於降低鴉片類藥物引起的呼吸抑制風險和確保患者病情穩定至關重要。聯合委員會於2024年7月發布的《2023年哨點事件資料年度回顧》分析了1,411起嚴重醫療事件。此統計數據凸顯了在獲得認證的醫療機構中，持續採用先進的生理監測標準以最大限度減少可預防性傷害的必要性。

氣道疾病和慢性呼吸系統疾病發生率的不斷上升進一步推動了對先進二氧化碳測量儀系統的需求。醫療保健人員越來越依賴呼氣末二氧化碳監測儀進行急性期管理和嚴重肺部疾病的長期評估。正如世界衛生組織 (WHO) 2024 年 3 月發布的《慢性阻塞性肺病(COPD)》概況介紹中所述，COPD 是全球第三大死因，每年導致 323 萬人死亡，這使得對可靠的通氣監測設備的需求持續成長。此外，這些設備在心血管急症的應用也不斷擴展。根據美國心臟協會 (AHA) 2024 年 1 月發布的《心臟病和中風統計——2024 年版》，美國每年發生超過 35.6 萬例院外心臟麻痹，凸顯了二氧化碳測量儀在評估復甦效果方面的關鍵作用。

市場挑戰

先進二氧化碳測量儀技術所需的高額初始投資是全球二氧化碳測量儀設備市場擴張的主要障礙。這種經濟限制使得發展中地區和預算緊張的醫療機構幾乎無法部署關鍵的監測系統，從而限制了市場的地域覆蓋範圍。如果醫療機構無法承擔初始購買成本，製造商在已開發地區將面臨市場飽和，同時難以進入潛力巨大的新興市場，這直接阻礙了收入成長。

此外，這種財務困境與操作這些先進設備所需的專業人員短缺密切相關。在那些既缺乏設備資金又缺乏分析數據的專業人員的地區，市場難以滲透。 2024年9月，世界麻醉醫師學會聯盟報告稱，由於這些資源限制，在資源匱乏的地區，臨床對呼氣末二氧化碳監測的需求與其實際可用性之間存在100%的差距。這一數字凸顯了人力資源和資金的匱乏如何阻礙了全球眾多患者獲得治療，嚴重限制了全球普及率和市場規模。

市場趨勢

隨著醫療機構越來越重視整合平台而非獨立設備以簡化臨床工作流程，多功能病患監測系統的整合發展正在迅速改變競爭格局。這一趨勢推動了二氧化碳測量儀二氧化碳監測技術與先進多功能監視器的整合，這些監視器可同時評估氧飽和度、血流動力學和腦功能，從而簡化床邊設備並提供患者病情穩定性的全面資訊。透過將呼吸動態整合到更廣泛的生理監測中心，製造商正在滿足加護病房和手術室對全面、先進的監測工具的需求，以支持複雜的決策。主要企業正在證明這種整合策略的成功。例如，Masimo在2024年6月的「投資者報告」中指出，包括氣體監測和呼氣末二氧化碳監測在內的高成長類別的耗材收入年成長率超過20%，顯示市場對這種整合診斷生態系統的需求強勁。

同時，無線連接技術的整合，實現了與電子健康記錄 (EHR) 的同步，顯著提升了監測基礎設施的性能，推動市場從基本的床邊顯示器向聯網數據智慧轉型。醫院正擴大部署連網的呼氣末二氧化碳二氧化碳測量儀系統，可自動將即時吐氣末二氧化碳資料傳輸至電子健康記錄或中央站，從而減少記錄錯誤並實現遠端病患監測。這種數位化變革使得醫院各科室能夠即時識別呼吸抑制，這與醫療物聯網 (IoMT) 和互通智慧醫院的整體趨勢相符。這項轉變的經濟影響巨大，皇家飛利浦於 2024 年 1 月發布的「2023 年第四季及全年業績」印證了這一點。該公司互聯護理業務的同店銷售額年增 5%，主要得益於監測業務兩位數的成長，凸顯了連網患者監測解決方案的巨大價值。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球二氧化碳監測設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件（OEM模組、其他）
    • 依應用領域（急診護理、疼痛管理、程序鎮靜、重症監護、其他）
    • 按技術（主流、邊緣、微流）
    • 依類型（攜帶式、獨立式、多參數）
    • 依最終用戶（醫院、門診中心等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美二氧化碳監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲二氧化碳監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區二氧化碳監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲二氧化碳監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲二氧化碳監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球二氧化碳監測設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Medtronic
  • Philips
  • Masimo
  • Smiths Medical
  • GE Healthcare
  • Drager
  • Welch Allyn
  • Mindray
  • Zoll Medical
  • Natus Medical

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25412

The Global Capnography Devices Market is projected to expand from USD 684.62 Million in 2025 to USD 1227.47 Million by 2031, exhibiting a CAGR of 10.22%. These noninvasive diagnostic instruments are essential for gauging carbon dioxide levels in exhaled breath to evaluate a patient's ventilation and circulatory health within clinical settings. The market's upward trajectory is primarily fueled by the increasing worldwide incidence of chronic respiratory ailments and the strict implementation of medical safety standards requiring continuous carbon dioxide tracking during sedation and anesthesia. Data from the Society of Critical Care Medicine in 2024 indicated that sepsis impacted roughly 50 million individuals globally, highlighting the urgent need for dependable physiological monitoring in intensive care units to effectively handle such dangerous conditions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 684.62 Million
Market Size 2031USD 1227.47 Million
CAGR 2026-203110.22%
Fastest Growing SegmentSidestream
Largest MarketNorth America

Conversely, a significant hurdle restricting wider market growth is the considerable capital expenditure needed for sophisticated capnography systems, which poses an entry barrier for medical facilities in economically disadvantaged areas. This financial impediment is frequently exacerbated by a shortage of skilled medical personnel qualified to precisely analyze capnographic readings, thereby restricting the extensive adoption of these vital technologies in healthcare networks operating under tight budgetary constraints.

Market Driver

Stringent regulatory requirements concerning the safety of procedural sedation and anesthesia act as a major market accelerator. Across the globe, professional societies and regulatory agencies are implementing strict protocols that mandate the continuous observation of end-tidal carbon dioxide to avert respiratory complications during surgeries. These measures are crucial for reducing dangers linked to opioid-induced respiratory depression and guaranteeing patient stability. The Joint Commission's July 2024 'Sentinel Event Data 2023 Annual Review' examined 1,411 sentinel events, a statistic that underscores the enduring necessity for elevated physiological monitoring benchmarks in accredited healthcare facilities to minimize preventable injuries.

The escalating frequency of airway and chronic respiratory conditions further intensifies the need for sophisticated capnography systems. Medical providers increasingly depend on capnometers for both acute management and long-term evaluation of severe lung diseases. As stated in the World Health Organization's March 2024 'Chronic Obstructive Pulmonary Disease' fact sheet, COPD ranks as the third primary cause of global mortality, responsible for 3.23 million deaths per year, generating a persistent demand for reliable ventilation monitoring instruments. Furthermore, the application of these devices in emergency cardiovascular scenarios is growing; the American Heart Association's 'Heart Disease and Stroke Statistics-2024 Update' from January 2024 noted over 356,000 annual out-of-hospital cardiac arrests in the US, reinforcing capnography's vital function in assessing resuscitation quality.

Market Challenge

The significant upfront investment necessary for advanced capnography technology represents a major obstacle hindering the Global Capnography Devices Market's expansion. This economic limitation effectively bars healthcare institutions in developing and budget-constrained areas from acquiring critical monitoring systems, consequently restricting the market's geographical scope. When medical centers cannot sustain the initial purchase expenses, manufacturers encounter saturation in developed regions while remaining unable to access high-potential emerging markets, which directly impedes revenue growth.

Moreover, this financial difficulty is closely linked to a deficiency in specialized staff needed to operate these sophisticated devices. The market struggles to penetrate areas that suffer from both insufficient funding for equipment and a lack of skilled professionals to analyze the resulting data. In September 2024, the World Federation of Societies of Anaesthesiologists reported a 100% disparity between the clinical requirement for capnography and its actual availability in low-resource environments due to these specific resource limitations. This figure emphasizes how workforce and financial shortages leave large global populations without access, establishing a strict limit on global adoption rates and market volume.

Market Trends

The shift toward converging with multi-parameter patient monitoring ecosystems is swiftly altering the competitive environment as healthcare facilities favor unified platforms over standalone units to improve clinical workflow efficiency. This movement involves embedding capnography capabilities into sophisticated multi-parameter monitors that concurrently assess oxygen saturation, hemodynamics, and brain function, thereby decluttering the bedside and offering a comprehensive perspective on patient stability. By integrating respiratory mechanics into wider physiological monitoring centers, manufacturers are meeting the need for all-encompassing, high-acuity surveillance tools that aid complex decision-making in intensive care units and operating theaters. The success of this integrated strategy is demonstrated by major industry players; for instance, Masimo Corporation's June 2024 'Investor Presentation' noted that consumable revenues for high-growth categories, including gas monitoring and capnography, expanded by over 20% annually, signaling strong uptake of these consolidated diagnostic ecosystems.

Concurrently, the integration of wireless connectivity for Electronic Health Record (EHR) synchronization is propelling major enhancements in monitoring infrastructure, transitioning the market from basic bedside display to networked data intelligence. Hospitals are increasingly funding connected capnography systems that automatically relay real-time end-tidal carbon dioxide data to electronic medical records and central stations, reducing documentation mistakes and facilitating remote patient observation. This digital evolution permits instant identification of respiratory depression across various hospital departments, consistent with the wider movement toward the Internet of Medical Things (IoMT) and interoperable smart hospitals. The financial significance of this transition is considerable, as evidenced by Royal Philips in their January 2024 'Fourth Quarter and Annual Results 2023', where comparable sales in the Connected Care division rose by 5% for the year, driven largely by double-digit expansion in the Monitoring segment, highlighting the immense value placed on networked patient supervision solutions.

Key Market Players

  • Medtronic
  • Philips
  • Masimo
  • Smiths Medical
  • GE Healthcare
  • Drager
  • Welch Allyn
  • Mindray
  • Zoll Medical
  • Natus Medical

Report Scope

In this report, the Global Capnography Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Capnography Devices Market, By Component

  • OEM Modules
  • Others

Capnography Devices Market, By Application

  • Emergency Medicine
  • Pain Medicine
  • Procedural Sedation
  • Critical Care
  • Others

Capnography Devices Market, By Technology

  • Mainstream
  • Sidestream
  • Microstream

Capnography Devices Market, By Type

  • Hand-Held
  • Stand-Alone
  • Multi-Parameter

Capnography Devices Market, By End User

  • Hospitals
  • Ambulatory Care Centers
  • Others

Capnography Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Capnography Devices Market.

Available Customizations:

Global Capnography Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Capnography Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (OEM Modules, Others)
    • 5.2.2. By Application (Emergency Medicine, Pain Medicine, Procedural Sedation, Critical Care, Others)
    • 5.2.3. By Technology (Mainstream, Sidestream, Microstream)
    • 5.2.4. By Type (Hand-Held, Stand-Alone, Multi-Parameter)
    • 5.2.5. By End User (Hospitals, Ambulatory Care Centers, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Capnography Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Application
    • 6.2.3. By Technology
    • 6.2.4. By Type
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Capnography Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By Type
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Capnography Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By Type
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Capnography Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By Type
        • 6.3.3.2.5. By End User

7. Europe Capnography Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Application
    • 7.2.3. By Technology
    • 7.2.4. By Type
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Capnography Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Type
        • 7.3.1.2.5. By End User
    • 7.3.2. France Capnography Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Type
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Capnography Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Type
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Capnography Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Type
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Capnography Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Type
        • 7.3.5.2.5. By End User

8. Asia Pacific Capnography Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Application
    • 8.2.3. By Technology
    • 8.2.4. By Type
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Capnography Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Type
        • 8.3.1.2.5. By End User
    • 8.3.2. India Capnography Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Type
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Capnography Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Type
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Capnography Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Type
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Capnography Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Type
        • 8.3.5.2.5. By End User

9. Middle East & Africa Capnography Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Application
    • 9.2.3. By Technology
    • 9.2.4. By Type
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Capnography Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Type
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Capnography Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Type
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Capnography Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Type
        • 9.3.3.2.5. By End User

10. South America Capnography Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Application
    • 10.2.3. By Technology
    • 10.2.4. By Type
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Capnography Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Type
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Capnography Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Type
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Capnography Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Type
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Capnography Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Philips
  • 15.3. Masimo
  • 15.4. Smiths Medical
  • 15.5. GE Healthcare
  • 15.6. Drager
  • 15.7. Welch Allyn
  • 15.8. Mindray
  • 15.9. Zoll Medical
  • 15.10. Natus Medical

16. Strategic Recommendations

17. About Us & Disclaimer